Scientific American

Compound weight-loss drugs are everywhere. The FDA is cracking down

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Medical spas, compounded drugs in focus as Indiana lawmakers hear warnings — and pushback

Indiana lawmakers are weighing new guardrails around drug compounding amid warnings that patients are receiving powerful prescription treatments in settings that operate largely outside state ...
National Law Review

FDA Tightens the Belt on GLP-1 Compounding, Escalating Threat of Enforcement

Key Takeaways On Feb. 6, 2026, FDA announced that it would take action to restrict access to GLP-1 ingredients for non-FDA ...
STAT

Hims is in the crosshairs. Is a crackdown coming for compounding?

A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.
Newsmax on MSN

FDA moves to restrict compounding GLP-1 ingredients

FDA Moves to Restrict Compounding GLP-1 Ingredients ...
Fierce Healthcare

White-label telehealth provider, pharmacy sued over 'snake oil' compounded oral GLP-1

OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. | The complaint ...
Healio

The benefits and risks of compounding pharmacies

Please provide your email address to receive an email when new articles are posted on . As of the end of October, 28 deaths resulting from the use of poorly prepared compounded medications by a ...
Yahoo Finance

United States Compounding Pharmacy Market Industry Outlook 2024-2029: Growing Demand for Compounded Bioidentical Menopausal Hormone Therapy (BMHT) Among Women Drives Market Growth

Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "U.S. Compounding Pharmacy Market - Industry Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering. The U.S.